These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 2795243

  • 1. Stimulation of gastric inhibitory polypeptide release in ob/ob mice by oral administration of sugars and their analogues.
    Flatt PR, Kwasowski P, Bailey CJ.
    J Nutr; 1989 Sep; 119(9):1300-3. PubMed ID: 2795243
    [Abstract] [Full Text] [Related]

  • 2. Gastric inhibitory polypeptide and insulin responses to orally administered amino acids in genetically obese hyperglycemic (ob/ob) mice.
    Flatt PR, Kwasowski P, Howland RJ, Bailey CJ.
    J Nutr; 1991 Jul; 121(7):1123-8. PubMed ID: 2051232
    [Abstract] [Full Text] [Related]

  • 3. Evidence for preferential stimulation of gastric inhibitory polypeptide secretion in the rat by actively transported carbohydrates and their analogues.
    Sykes S, Morgan LM, English J, Marks V.
    J Endocrinol; 1980 May; 85(2):201-7. PubMed ID: 7400708
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of diets rich in sucrose, coconut fat and safflowerseed oil on the development of the obese hyperglycaemic (ob/ob) syndrome in mice.
    Flatt PR, Bailey CJ, Kwasowski P, Swanston-Flatt SK.
    Diabetes Res; 1990 Jan; 13(1):23-8. PubMed ID: 2097092
    [Abstract] [Full Text] [Related]

  • 6. Active immunisation against gastric inhibitory polypeptide (GIP) improves blood glucose control in an animal model of obesity-diabetes.
    Irwin N, McClean PL, Patterson S, Hunter K, Flatt PR.
    Biol Chem; 2009 Jan; 390(1):75-80. PubMed ID: 18937625
    [Abstract] [Full Text] [Related]

  • 7. Immunoreactive gastric inhibitory polypeptide and K cell hyperplasia in obese hyperglycaemic (ob/ob) mice fed high fat and high carbohydrate cafeteria diets.
    Bailey CJ, Flatt PR, Kwasowski P, Powell CJ, Marks V.
    Acta Endocrinol (Copenh); 1986 Jun; 112(2):224-9. PubMed ID: 3526784
    [Abstract] [Full Text] [Related]

  • 8. Gastric inhibitory polypeptide (GIP) release by actively transported, structurally similar carbohydrates.
    Sirinek KR, Levine BA, O'Dorisio TM, Cataland S.
    Proc Soc Exp Biol Med; 1983 Jul; 173(3):379-85. PubMed ID: 6867011
    [Abstract] [Full Text] [Related]

  • 9. Detection of glycated gastric inhibitory polypeptide within the intestines of diabetic obese (ob/ob) mice.
    Mooney MH, Abdel-Wahab YH, Morgan LM, O'Harte FP, Flatt PR.
    Endocrine; 2001 Dec; 16(3):167-71. PubMed ID: 11954659
    [Abstract] [Full Text] [Related]

  • 10. Metabolic effects of glucose, mannose, galactose, and fructose in man.
    Ganda OP, Soeldner JS, Gleason RE, Cleator IG, Reynolds C.
    J Clin Endocrinol Metab; 1979 Oct; 49(4):616-22. PubMed ID: 479351
    [Abstract] [Full Text] [Related]

  • 11. Fatty acid derivatised analogues of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic properties.
    Kerr BD, Irwin N, O'Harte FP, Bailey CJ, Flatt PR, Gault VA.
    Biochem Pharmacol; 2009 Oct 15; 78(8):1008-16. PubMed ID: 19523458
    [Abstract] [Full Text] [Related]

  • 12. Effects of fatty acid chain length and saturation on gastric inhibitory polypeptide release in obese hyperglycaemic (ob/ob) mice.
    Kwasowski P, Flatt PR, Bailey CJ, Marks V.
    Biosci Rep; 1985 Aug 15; 5(8):701-5. PubMed ID: 4063474
    [Abstract] [Full Text] [Related]

  • 13. Effect of graded intraduodenal glucose infusions on the release and physiological action of gastric inhibitory polypeptide.
    McCullough AJ, Miller LJ, Service FJ, Go VL.
    J Clin Endocrinol Metab; 1983 Feb 15; 56(2):234-41. PubMed ID: 6337173
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of the antidiabetic activity of DPP IV resistant N-terminally modified versus mid-chain acylated analogues of glucose-dependent insulinotropic polypeptide.
    Irwin N, Clarke GC, Green BD, Greer B, Harriott P, Gault VA, O'Harte FP, Flatt PR.
    Biochem Pharmacol; 2006 Sep 14; 72(6):719-28. PubMed ID: 16859646
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Biological activity and antidiabetic potential of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide, GIP(1-16) and (Pro3)GIP(1-16).
    Irwin N, Green BD, Parker JC, Gault VA, O'Harte FP, Flatt PR.
    Regul Pept; 2006 Jul 15; 135(1-2):45-53. PubMed ID: 16675042
    [Abstract] [Full Text] [Related]

  • 18. Selective sodium-dependent glucose transporter 1 inhibitors block glucose absorption and impair glucose-dependent insulinotropic peptide release.
    Dobbins RL, Greenway FL, Chen L, Liu Y, Breed SL, Andrews SM, Wald JA, Walker A, Smith CD.
    Am J Physiol Gastrointest Liver Physiol; 2015 Jun 01; 308(11):G946-54. PubMed ID: 25767259
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the subchronic antidiabetic effects of DPP IV-resistant GIP and GLP-1 analogues in obese diabetic (ob/ob) mice.
    Irwin N, McClean PL, Flatt PR.
    J Pept Sci; 2007 Jun 01; 13(6):400-5. PubMed ID: 17486662
    [Abstract] [Full Text] [Related]

  • 20. Effect of Miglitol (Bay m1099), a new alpha-glucosidase inhibitor, on glucose, insulin, C-peptide and GIP responses to an oral sucrose load in patients with post-prandial hypoglycaemic symptoms.
    Renard E, Parer-Richard C, Richard JL, Jureidini S, Orsetti A, Mirouze J.
    Diabete Metab; 1991 Jun 01; 17(3):355-62. PubMed ID: 1884880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.